Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University462 Ruijin Hospital282 Shanghai Zhongshan Hospital169 RenJi Hospital133 Children's Hospital of Fudan University84
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Shanghai

3879 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Fudan University
Phase 2
106
Shanghai
2026-01
Not yet open
A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer
NCT07337031Primary Hepatocellular Carcinoma, Unresectable Liver Cancer
Eastern Hepatobiliary Surgery Hospital
Not applicable
193
Shanghai
2026-01
Not yet open
Ruijin Hospital
Early Phase 1
15
Shanghai
2026-01
Recruiting
Cytori Therapeutics
Not applicable
48
Guangzhou, Shanghai
2025-12-31
Not yet open
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 1
24
Shanghai
2025-12-31
Recruiting
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
158
Shanghai
2025-12-31
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
32
Shanghai
2025-12-31
Not yet open
Shanghai East Hospital
Not applicable
270
Shanghai
2025-12-31
Recruiting
Shanghai East Hospital
Observational
100
Shanghai
2025-12-31
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
88
Shanghai
2025-12-31
Not yet open
Shanghai MicroPort EP MedTech Co., Ltd.
Not applicable
20
Shanghai
2025-12-31
Not yet open
Fudan University
Phase 1
66
Shanghai
2025-12-30
Not yet open
Changhai Hospital
Early Phase 1
18
Shanghai
2025-12-30
Recruiting
Sinocelltech Ltd.
Phase 3
246
Shanghai
2025-12-30
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
240
Shanghai
2025-12-30
Recruiting
Tongji University
Phase 1
36
Shanghai
2025-12-30
Not yet open
Shanghai Zhongshan Hospital
Phase 2
90
Shanghai
2025-12-30
Recruiting
Shanghai AB PharmaTech Ltd.
Phase 2
110
Luoyang, Nanyang, Nanchang, Liaocheng, Shanghai, Taiyuan, Neijiang
2025-12-30
Recruiting
Xian-Janssen Pharmaceutical Ltd.
Phase 4
78
Guangzhou, Hangzhou, Hefei, Shanghai
2025-12-30
Active, closed
Pilot Trial of Colchicine for Graft Failure in CABG
NCT06802926CABG, Graft Failure, Colchicine
DrugColchicine
Ruijin Hospital
Phase 4
100
Shanghai
2025-12-29
By invitation
ShuGuang Hospital
Not applicable
80
Shanghai
2025-12-29
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
30
Shanghai
2025-12-29
Recruiting
Sanofi
Phase 2
144
Beijing, Changsha, Hangzhou, Shanghai, Wuhan
2025-12-29
Recruiting
Shanghai Henlius Biotech
Early Phase 1
254
Shanghai, Xi'an
2025-12-29
Recruiting
Shanghai Xinzhi BioMed Co., Ltd.
Phase 1
18
Shanghai
2025-12-27
Recruiting
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
NCT07265349Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure, Chronic Ischemic Cardiomyopathy
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
51
Shanghai
2025-12-26
Recruiting
Nanjing Zenshine Pharmaceuticals
Phase 1
80
Shanghai
2025-12-26
Recruiting
Shanghai 6th People's Hospital
Phase 2
46
Shanghai
2025-12-25
Recruiting
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Phase 1
40
Shanghai
2025-12-25
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 2
40
Shanghai
2025-12-24
Active, closed
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
319
Shanghai
2025-12-24
Recruiting
Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases
NCT07322718Relapsed/Refractory B Cell-Mediated Autoimmune Diseases
Ruijin Hospital
Early Phase 1
27
Shanghai
2025-12-24
Recruiting
ctDNA-guided Treatment Decision-making
NCT07394218Metastatic Breast Cancer ( HER2 Negative), ctDNA
DrugIvonescimab
Fudan University
Phase 2
122
Shanghai
2025-12-24
Not yet open
Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd.
Phase 1
80
Shanghai
2025-12-23
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
400
Wuhan, Shanghai
2025-12-23
Recruiting
Eye & ENT Hospital of Fudan University
Phase 2
116
Harbin, Jinan, Beijing, Shanghai, Tianjin
2025-12-22
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
172
Shanghai
2025-12-22
Recruiting
GenSci143 in Participants With Advanced Solid Tumors
NCT07252414Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
180
Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Shanghai, Taiyuan, Hangzhou
2025-12-20
Recruiting
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
300
Shanghai
2025-12-20
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
4
Shanghai
2025-12-19
Recruiting
RenJi Hospital
Not applicable
25
Shanghai
2025-12-19
Recruiting
Janssen Research & Development, LLC
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin
2025-12-19
Recruiting
TCRx Therapeutics Co.Ltd
Phase 1
30
Shanghai
2025-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2
140
Nanjing, Nanchang, Shanghai, Chengdu
2025-12-19
Recruiting
Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies
NCT07309770Urachal Cancer, Advanced Solid Tumor Cancer, Antibody-drug Conjugates
DrugTrastuzumab Rezetecan
Sheng Zhang
Phase 2
90
Shanghai
2025-12-18
Recruiting
Hutchmed
Phase 1/2
147
Beijing, Changsha, Guangzhou, Hefei, Shanghai, Shenyang, Zhengzhou
2025-12-16
Recruiting
Nanjing Leads Biolabs Co.,Ltd
Phase 1
117
Bengbu, Beijing, Guangzhou, Changsha, Nanjing, Pingxiang, Shanghai, Taiyuan
2025-12-16
Recruiting
Fudan University
Not applicable
384
Shanghai
2025-12-15
Not yet open
Ruijin Hospital
Phase 2
23
Shanghai
2025-12-15
Recruiting
Ruijin Hospital
Phase 2
20
Shanghai
2025-12-15
Recruiting
Ruijin Hospital
Phase 2
20
Shanghai
2025-12-15
Recruiting
Phase II Study of LM-24C5
NCT07387081Advanced Solid Tumor Cancer
DrugLM-24C5
LaNova Medicines Limited
Phase 2
130
Fuzhou, Shanghai
2025-12-15
Recruiting
Ruijin Hospital
Not applicable
50
Shanghai
2025-12-15
Not yet open
Fudan University
Not applicable
614
Shanghai
2025-12-15
Recruiting
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
NCT07366528Gastric Cancer (GC), Adjuvant Chemotherapy, Stage 3 Cancer, Docetaxel
DrugsTeysuno·Docetaxel·Oxaliplatin
Ruijin Hospital
Phase 3
387
Shaoguan, Shanghai
2025-12-15
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
98
Shanghai
2025-12-15
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3
420
Shanghai
2025-12-12
Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 2
110
Shanghai
2025-12-12
Recruiting
Ruijin Hospital
Observational
500
Shanghai
2025-12-12
Recruiting
A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+
NCT07326215Acute Respiratory Distress Syndrome, Acute Kidney Injury
Vantive Health LLC
Not applicable
99
Beijing, Guangzhou, Shenzhen, Harbin, Nanjing, Nanchang, Shanghai, Chengdu
2025-12-11
Recruiting
BeOne Medicines
Phase 1
86
Beijing, Chongqing, Xiamen, Guangzhou, Harbin, Changsha, Nanjing, Shanghai
2025-12-11
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Early Phase 1
36
Zhengzhou, Nanjing, Xuzhou, Shanghai, Xi’an
2025-12-10
Recruiting
Danyang Huichuang Medical Equipment Co., Ltd.
Phase 3
320
Beijing, Shijiazhuang, Baotou, Suzhou, Xi'an, Shanghai, Taiyuan, Tianjin
2025-12-10
Not yet open
Fudan University
Observational
16,509
Shanghai
2025-12-10
Not yet open
The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy
NCT07277088Pulmonary Nodules, Lung Cancer (Diagnosis), Percutaneous Needle Biopsy, Transthoracic Needle Biopsy
Jiayuan Sun
Not applicable
158
Shanghai
2025-12-10
Recruiting
AbbVie
Phase 2/3
490
Guangzhou, Nanchang, Shanghai, Ürümqi
2025-12-10
Not yet open
Abbisko Therapeutics Co, Ltd
Phase 1/2
110
Beijing, Zhengzhou, Wuhan, Shanghai, Chengde, Chengdu, Hangzhou
2025-12-10
Recruiting
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
NCT07342205Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine
Phase 2/3
60
Shanghai
2025-12-10
Recruiting
HC Biopharma Inc.
Phase 2
50
Shanghai
2025-12-09
Recruiting
Fudan University
Not applicable
30
Shanghai
2025-12-09
Recruiting
Shanghai Zhongshan Hospital
Observational
1,030
Shanghai
2025-12-09
Recruiting
Pfizer
Phase 2/3
550
Guangzhou, Shanghai
2025-12-09
Recruiting
Tongji Hospital
Observational
40
Beijing, Guangzhou, Wuhan, Shanghai, Hangzhou
2025-12-09
Recruiting
Eli Lilly and Company
Phase 2
60
Beijing, Chengdu, Guangzhou, Luoyang, Shanghai, Xuzhou
2025-12-08
Not yet open
Biotyx Medical (Shenzhen) Co., Ltd.
Not applicable
15
Shanghai
2025-12-08
Recruiting
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
NCT07335705IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation
Changhai Hospital
Observational
1,000
Shanghai
2025-12-08
Not yet open
The Hong Kong Polytechnic University
Not applicable
132
Shanghai
2025-12-08
Recruiting
Changhai Hospital
Phase 2
31
Shanghai
2025-12-08
Recruiting
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
NCT07275840Neovascular Age-related Macular Degeneration
DrugIBI302
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase 2
800
Shanghai
2025-12-05
Recruiting
Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors
NCT07299747Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc
Phase 1/2
255
Shanghai
2025-12-04
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
100
Shanghai, Hangzhou
2025-12-04
Recruiting
Takeda
Phase 3
110
Beijing, Guangzhou, Changsha, Hangzhou, Shanghai
2025-12-04
Recruiting
Daiichi Sankyo
Phase 1
60
Guangzhou, Shanghai, Wenzhou
2025-12-03
Recruiting
Bristol-Myers Squibb
Phase 3
366
Beijing, Guangzhou, Shenzhen, Handan, Zhengzhou, Changsha, Jinan, Shanghai
2025-12-03
Recruiting
GlaxoSmithKline
Phase 3
450
Shijiazhuang, Shanghai, Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan
2025-12-03
Recruiting
Pfizer
Phase 3
450
Beijing, Shenzhen, Changsha, Nanchang, Hangzhou, Shanghai
2025-12-02
Recruiting
Sanofi
Phase 2
37
Beijing, Shanghai, Shenzhen, Suzhou
2025-12-02
Recruiting
Monash University
Observational
480
Shanghai
2025-12-02
Not yet open
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-12-01
Recruiting
Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy
NCT06728826Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion
Changhai Hospital
Not applicable
650
Shanghai
2025-12-01
Not yet open
EFG vs IVIG in TAMG
NCT07231523Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital
Phase 3
64
Shanghai
2025-12-01
Recruiting
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
NCT07207824Bladder (Urothelial, Transitional Cell) Cancer, NMIBC
Fudan University
Phase 3
182
Shanghai
2025-12-01
Recruiting
Huashan Hospital
Phase 4
300
Shanghai
2025-12-01
Not yet open
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
NCT07208526Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy, TDTP-RECIST, GOLP Regimen
Shanghai Zhongshan Hospital
Not applicable
270
Shanghai
2025-12-01
Recruiting
STROKE 120 ACTION Trial
NCT07135310Ischemic Stroke
Shanghai Minhang Central Hospital
Not applicable
1,696,000
Shanghai
2025-12-01
Recruiting
Asiaticoside for Treating Overweight/Obesity
NCT07241533Overweight , Obesity
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2025-12-01
Recruiting
Valsalva SBP Drop and LVOT Obstruction
NCT07483125HCM, oHCM, nHCM
Shanghai Zhongshan Hospital
Observational
800
Shanghai
2025-12-01
Active, closed
Research on the Application of Decision Tree in Child Life
NCT07325890Psychosocial Intervention, Non-Randomized Controlled Trials
Children's Hospital of Fudan University
Not applicable
40
Shanghai
2025-12-01
Recruiting
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
NCT04908696Glottic Carcinoma, Supraglottic Carcinoma, Subglottic Carcinoma, Pyriform Sinus Carcinoma
Eye & ENT Hospital of Fudan University
Observational
1,000
Shanghai
2025-12-01
By invitation
Ruijin Hospital
Not applicable
60
Shanghai
2025-12-01
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
84
Beijing, Fuzhou, Nanchang, Jinan, Shanghai, Hangzhou
2025-12-01
Recruiting
Pfizer
Phase 1/2
138
Shanghai
2025-12-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
10,000
Zunyi, Jiangxi, Shanghai, Ningbo
2025-12-01
Active, closed
UCB Biopharma SRL
Phase 4
40
Beijing, Changchun, Changsha, Fuzhou, Guangzhou, Jinan, Shanghai, Shenzhen
2025-12-01
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-12
Not yet open
Shanghai Changzheng Hospital
Observational
1,100
Beijing, Guangzhou, Nanjing, Suzhou, Shanghai, Chengdu, Ningbo
2025-12
Not yet open
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Shanghai
2025-12
Not yet open
A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma
NCT07239986Hepatocellular Carcinoma (HCC)
DrugBB102
Broadenbio Ltd., Co.
Phase 2
60
Hefei, Shanghai
2025-12
Not yet open
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 4
1,244
Shanghai
2025-11-30
Not yet open
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
NCT07268794Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma), Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
DrugDocetaxel
Fudan University
Phase 2
112
Shanghai
2025-11-30
Recruiting
Chengdu New Radiomedicine Technology Co. LTD.
Phase 1
132
Shanghai, Tianjin
2025-11-29
Recruiting
RenJi Hospital
Not applicable
10
Shanghai
2025-11-28
Recruiting
Single-dose,First-in-human of KLA478
NCT07240675Healthy Volunteers
Hunan Kelun Pharmaceutical Co., Ltd.
Phase 1
40
Shanghai
2025-11-26
Recruiting
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
NCT07742332EGFR, NSCLC (Non-small Cell Lung Cancer), Locally Advanced Non-Small Cell Lung Cancer, Radiotherapy
Peng Zhang
Phase 2
160
Shanghai
2025-11-25
Recruiting
AbbVie
Phase 2
180
Beijing, Zhengzhou, Wuhan, Nanchang, Shanghai, Chengdu
2025-11-25
Not yet open
Efficacy and Safety of Stapokibart in Non-Allergic Rhinitis With Eosinophilia Syndrome
NCT07240376Non-Allergic Rhinitis With Eosinophilia Syndrome
DrugStapokibart
Huazhong University of Science and Technology
Not applicable
90
Guangzhou, Wuhan, Xiangyang, Nanchang, Chengdu, Beijing, Shanghai
2025-11-25
Recruiting
Eye & ENT Hospital of Fudan University
Early Phase 1
30
Shanghai
2025-11-24
Not yet open
Zhang Jianguo
Not applicable
86
Beijing, Wuhan, Nanjing, Dalian, Jinan, Shanghai, Tianjin, Hangzhou
2025-11-24
Recruiting
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
NCT07029178Radiation Induced Oral Mucositis, Radiodermatitis
DrugTaurine
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
160
Shanghai
2025-11-24
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 4
624
Shanghai
2025-11-24
Recruiting
Eli Lilly and Company
Phase 2
400
Changsha, Hangzhou, Huzhou, Jinan, Shanghai, Shijiazhuang, Tianjin, Xiamen
2025-11-24
Recruiting
Biocity Biopharmaceutics Co., Ltd.
Phase 1
180
Shanghai
2025-11-24
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Jinan, Shanghai, Shenyang
2025-11-24
Recruiting
Tianjin Puli Ark Medical Technology Co., Ltd.
Not applicable
40
Shanghai
2025-11-21
Recruiting
Huashan Hospital
Phase 4
426
Beijing, Liupanshui, Nayong, Shanghai, Hangzhou
2025-11-21
Recruiting
HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer
NCT07232875KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
DrugHRS-4642
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
588
Shanghai
2025-11-21
Recruiting
Ruijin Hospital
Not applicable
90
Shanghai
2025-11-21
Not yet open
The Affiliated Hospital of Xuzhou Medical University
Phase 4
1,160
Fuyang, Huai'an, Lianyungang, Nanjing, Suqian, Xuzhou, Beijing, Shanghai
2025-11-20
Recruiting
Pfizer
Phase 2
165
Fuzhou, Guangzhou, Shanghai, Beijing
2025-11-20
Not yet open
Yan Li
Phase 3
220
Shanghai
2025-11-20
Active, closed
MedtronicNeuro
Not applicable
61
Beijing, Guangzhou, Shanghai, Chengdu
2025-11-19
Recruiting
Everest Medicines (Beijing) Co., Ltd.
Phase 1/2
94
Changsha, Nanjing, Shanghai
2025-11-17
Recruiting
Beyang Therapeutics Co., Ltd.
Phase 1
32
Shanghai
2025-11-17
Recruiting
Ruijin Hospital
Phase 2
35
Sanming, Changchun, Shanghai
2025-11-17
Recruiting
Shanghai Mental Health Center
Not applicable
120
Shanghai
2025-11-15
Recruiting
Fudan University
Observational
3,000
Shanghai
2025-11-15
Recruiting
Changhai Hospital
Early Phase 1
36
Shanghai
2025-11-15
Recruiting
A Clinical Study of PA5 in Patients With Advanced Solid Tumors
NCT07702162Advanced Solid Tumors, Cancer
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1
49
Fuzhou, Shanghai
2025-11-14
Recruiting
UCB Biopharma SRL
Phase 3
320
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Shanghai, Shenzhen
2025-11-14
Recruiting
Ruijin Hospital
Phase 3
150
Shanghai
2025-11-14
Recruiting
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2
444
Shanghai
2025-11-13
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
2,000
Shanghai
2025-11-13
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2
200
Shanghai
2025-11-12
Recruiting
Regend Therapeutics
Early Phase 1
12
Shanghai
2025-11-11
Recruiting
Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
NCT07081984HPV 16+ Recurrent or Metastatic Cancer, HNSCC, Cervical Cancer
Therorna
Phase 1
12
Shanghai
2025-11-11
Recruiting
Shanghai Zhongshan Hospital
Phase 4
350
Shanghai
2025-11-11
Recruiting
Symplicity China Study
NCT07081243Resistant Hypertension
Medtronic Vascular
Observational
500
Shanghai
2025-11-11
Recruiting
AstraZeneca
Phase 1
40
Chengdu, Hangzhou, Nanjing, Shanghai, Wuhan, Xiamen
2025-11-10
Recruiting
BeOne Medicines
Phase 1
63
Beijing, Chongqing, Xiamen, Harbin, Zhengzhou, Shanghai, Chengdu, Hangzhou
2025-11-10
Active, closed
Guangdong Raynovent Biotech Co., Ltd
Phase 3
157
Shanghai
2025-11-08
Not yet open
First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University
Not applicable
60
Shanghai
2025-11-08
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
232
Beijing, Nanjing, Shanghai, Tianjin, Wuhan
2025-11-07
Active, closed
Ruijin Hospital
Observational
275
Shanghai
2025-11-07
Recruiting
Grit Biotechnology
Early Phase 1
22
Shanghai
2025-11-07
Not yet open
Shanghai Jiao Tong University School of Medicine
Observational
120
Shanghai
2025-11-06
Recruiting
Sanofi
Phase 2
208
Chengdu, Guangzhou, Shanghai, Ürümqi
2025-11-06
Recruiting
Shanghai Geriatric Medical Center
Not applicable
390
Shanghai
2025-11-06
Recruiting
Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
NCT07554976Percutaneous Intervention Via Common Femoral Vein
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
136
Shanghai
2025-11-05
Recruiting
Shanghai Synvida Biotechnology Co.,Ltd.
Phase 2
48
Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing, Neimeng, Shanghai, Tianjin
2025-11-04
Recruiting
Fudan University
Phase 2
73
Shanghai
2025-11-04
Active, closed
Takeda
Phase 2
207
Wuhan, Xi'an, Shanghai, Kunming, Hangzhou
2025-11-03
Recruiting
Huashan Hospital
Phase 3
890
Shanghai
2025-11-03
Recruiting
The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status
NCT07383974Healthy Volunteers, Dietary Supplementation, Skin Health, Health Status
ChinaNorm
Not applicable
120
Shanghai
2025-11-03
Recruiting
Triple Branched Stent Graft System for Aortic Arch Lesions
NCT07067840Aortic Arch Aneurysm, Aortic Arch Pseudoaneurysm, Aortic Arch Ulcer
Changhai Hospital
Not applicable
96
Shanghai
2025-11-03
Recruiting
A IIT Study of 177Lu-DOTA-SNA040
NCT07595237Advanced Solid Tumors (Such as Gastric Cancer), Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction), Advanced Solid Tumors (Such as Pancreatic Cancer), Advanced Solid Tumors (Such as Cholangiocarcinoma)
SmartNuclide Biopharma
Early Phase 1
12
Shanghai
2025-11-01
Recruiting
Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)
NCT07701876Heart Failure, Heart Failure and Reduced Ejection Fraction
Ruijin Hospital Luwan Branch
Observational
1,740
Shanghai
2025-11-01
Not yet open
Pulsed Field Ablation of SVC and PV in Paroxysmal Atrial Fibrillation (PASPA Study)
NCT07191626Paroxysmal Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)
Changhai Hospital
Not applicable
650
Shanghai
2025-11-01
Recruiting
Chang Chen
Observational
244
Shanghai
2025-11-01
Recruiting
Fudan University
Phase 2
126
Shanghai
2025-11-01
Recruiting
Fudan University
Not applicable
90
Shanghai
2025-11-01
Recruiting
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
NCT07157631Liver Transplantation, Tranexamic Acid, End-stage Liver Disease (ESLD)
DrugTranexamic Acid
RenJi Hospital
Not applicable
1,546
Shanghai
2025-11-01
By invitation
Ruijin Hospital
Not applicable
40
Shanghai
2025-11-01
Not yet open
Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethered Cord Syndrome Post-Surgery
NCT07062133Postoperative Neurogenic Lower Urinary Tract Dysfunction Secondary to Tethered Cord Syndrome
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
50
Shanghai
2025-11-01
Recruiting
Grit Biotechnology
Phase 1/2
78
Shanghai, Chengdu
2025-11-01
Recruiting
Kind Pharmaceuticals LLC
Phase 3
300
Shanghai
2025-10-31
Recruiting
Eli Lilly and Company
Phase 3
1,205
Beijing, Chengdu, Guangzhou, Harbin, Luoyang Shi, Nanjing, Shanghai, Tianjin
2025-10-31
Recruiting
Shandong New Time Pharmaceutical Co., LTD
Phase 1
64
Shanghai
2025-10-30
Recruiting
Pfizer
Phase 2
200
Beijing, Guangzhou, Shijiazhuang, Shanghai, Tianjin, Hangzhou
2025-10-30
Not yet open
RenJi Hospital
Phase 2
31
Shanghai
2025-10-30
By invitation
Eye & ENT Hospital of Fudan University
Observational
43
Shanghai
2025-10-30
By invitation
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
24
Shanghai
2025-10-30
Recruiting
Ming Zhong
Observational
20
Shanghai
2025-10-30
Recruiting
A Study of Ivonescimab in First-Line ES-SCLC
NCT07245446Extensive-stage Small Cell Lung Cancer (ES-SCLC)
DrugsLigufalimab·Cadonilimab·Ivonescimab·Etoposide
Akeso
Phase 2
180
Beijing, Xi'an, Shanghai
2025-10-29
By invitation
Luye Pharma Group Ltd.
Phase 1
98
Shanghai
2025-10-28
Recruiting
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
NCT07301242Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip, Femoral Neck Fractures
DrugCiprofol
Shanghai Geriatric Medical Center
Observational
50
Shanghai
2025-10-28
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
444
Shanghai
2025-10-24
Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
240
Shanghai
2025-10-24
Recruiting
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
NCT07091305Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy, Induction Therapy, Consolidation Immunotherapy
DrugLenvatinib
Shanghai Chest Hospital
Phase 2
28
Shanghai
2025-10-23
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
740
Shenyang, Shanghai
2025-10-23
Recruiting
Eli Lilly and Company
Phase 2
531
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai
2025-10-22
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07213791Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms, Colorectal Neoplasms
Eli Lilly and Company
Phase 1
340
Shanghai
2025-10-22
Recruiting
Usynova Pharmaceuticals Ltd.
Not applicable
140
Shanghai
2025-10-21
Active, closed
Jian Zhuo
Observational
1,650
Shanghai
2025-10-20
Recruiting
RenJi Hospital
Observational
150
Shanghai
2025-10-20
Recruiting
Ruijin Hospital
Phase 1
12
Shanghai
2025-10-20
Recruiting
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
NCT07150208Breast Cancer With Brain Metastasis, HER2-low Expressing Breast Cancer
DrugsHLX04·Trastuzumab deruxtecan·Bevacizumab
Fudan University
Phase 2
140
Shanghai
2025-10-20
Not yet open
Shanghai Jiao Tong University School of Medicine
Observational
55
Shanghai
2025-10-20
Recruiting
Eastern Hepatobiliary Surgery Hospital
Phase 2/3
20
Shanghai
2025-10-20
By invitation
NeuShen Therapeutics
Phase 2
150
Shanghai
2025-10-20
Recruiting
Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
NCT05465252Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
24
Shanghai
2025-10-17
Recruiting
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
720
Shanghai
2025-10-17
Recruiting
Wayshine Biopharm, Inc.
Phase 1/2
48
Shanghai
2025-10-17
Recruiting
Construction of a Portal Hypertension Biobank
NCT07419724Variceal Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-10-16
Active, closed
Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer
NCT07262671NSCLC (Advanced Non-small Cell Lung Cancer)
Fudan University
Observational
100
Shanghai
2025-10-16
Recruiting
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT07209761Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis
DrugsPretomanid·Bedaquiline·Linezolid·Moxifloxacin
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
532
Beijing, Fuzhou, Shenzhen, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2025-10-16
Recruiting
Huashan Hospital
Not applicable
156
Shanghai
2025-10-15
Not yet open
Fudan University
Phase 2
104
Shanghai
2025-10-15
Recruiting
Fudan University
Not applicable
120
Shanghai
2025-10-15
Recruiting
Yan Xing
Early Phase 1
4
Shanghai
2025-10-15
Not yet open
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2
104
Shanghai
2025-10-15
Recruiting
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Phase 4
300
Shanghai
2025-10-15
Recruiting
To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
NCT07303465KRAS G12D Mutations, Pancreatic Ductal Adenocarcinoma (PDAC)
DrugRNK08954
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 2
60
Nanjing, Shanghai
2025-10-14
Recruiting
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182Healthy Volunteers, Alzheimer Disease, Amyloid, Plaque, Amyloid
DrugLY4405094
Eli Lilly and Company
Phase 1
68
Beijing, Minhang District, Shanghai
2025-10-14
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
825
Shanghai
2025-10-14
Active, closed
L'Oreal
Not applicable
35
Shanghai
2025-10-13
Recruiting
Takeda
Phase 3
20
Beijing, Guangzhou, Jihan, Shanghai, Suzhou, Tianjin, Wuhan
2025-10-13
Recruiting
Children's Hospital of Fudan University
Not applicable
160
Shanghai
2025-10-13
Recruiting
Changhai Hospital
Not applicable
1,250
Baotou, Beijing, Hangzhou, Hunan, Lanzhou, Shandong, Shanghai, Yunnan
2025-10-13
Active, closed
L'Oreal
Not applicable
66
Shanghai
2025-10-11
Recruiting
Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
NCT07283575Metastatic Colorectal Cancer ctDNA Surveillance
Fudan University
Observational
497
Shanghai
2025-10-10
Recruiting
The Fever Clinic Acute Respiratory Cohort
NCT07278700Acute Respiratory Infections, Febrile Illnesses, Community-acquired Pneumonia, Viral Respiratory Tract Infections
Fudan University
Observational
1,000
Shanghai
2025-10-10
Recruiting
Adicet Therapeutics
Phase 1
25
Shanghai
2025-10-10
Not yet open
Fudan University
Phase 2
37
Shanghai
2025-10-10
Recruiting
Belief BioMed (Beijing) Co., Ltd
Phase 1
81
Shenzhen, Shanghai
2025-10-09
Active, closed
Wearable NH₃ Sensor for Remote Non-invasive Monitoring and Diagnosis of Diabetic Kidney Disease
NCT07875010Diabetic Nephropathies MeSH:D003928, Diabetes Mellitus, Type 2, Kidney Diseases
Shanghai Pudong Hospital
Observational
380
Shanghai
2025-10-09
Not yet open
Amway (China) R&D Center
Observational
200
Shanghai
2025-10-09
By invitation
Fudan University
Not applicable
92
Shanghai
2025-10-08
Recruiting
Sanofi
Phase 3
980
Luoyang, Wuhan, Changshu, Chengdu, Jinhua, Luzhou, Shanghai
2025-10-08
By invitation
Autologous Islet Transplantation for Diabetes
NCT07118475Diabetes Mellitus, Type 2
Shanghai Zhongshan Hospital
Early Phase 1
24
Shanghai
2025-10-07
Recruiting
Celgene
Phase 1/2
62
Suzhou, Shanghai
2025-10-07
Recruiting
Genentech, Inc.
Phase 1/2
285
Jinan, Shanghai, Tianjin, Fuzhou, Nanning
2025-10-07
Recruiting
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 1
86
Hangzhou, Shanghai
2025-10-05
Recruiting
Shanghai Mental Health Center
Not applicable
100
Shanghai
2025-10-01
Active, closed
Clinical Study of Compound Ciwujia Granules in the Treatment of Depression
NCT07085143Depression - Major Depressive Disorder, Depression Disorders
Shanghai Mental Health Center
Phase 4
60
Shanghai
2025-10-01
Recruiting
Children's Hospital of Fudan University
Observational
80
Shanghai
2025-10-01
Recruiting
Ruijin Hospital
Phase 4
50
Shanghai
2025-10-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
587
Shanghai
2025-10-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
58
Shanghai
2025-10-01
By invitation
Infiltration Pattern of Locally Advanced ESCC
NCT07567716Esophageal Squamous Cell Carcinoma (ESCC), Infiltration, Tumour
Shanghai Chest Hospital
Observational
30
Shanghai
2025-10-01
Recruiting
Close Loop Smart Weaning for INO With PPHN
NCT06832163Persistent Pulmonary Hypertension of the Newborn, Inhaled Nitric Oxide
Children's Hospital of Fudan University
Not applicable
30
Shanghai
2025-10-01
Recruiting
Ruijin Hospital
Observational
25
Shanghai
2025-10-01
Not yet open
Spectrumedics Medical Technology(Shanghai)Co.,Ltd
Not applicable
180
Shanghai
2025-10-01
Not yet open
Fudan University
Observational
700
Shanghai
2025-10-01
Not yet open
Yanbing Li
Observational
594
Hangzhou, Baoding, Beijing, Shanghai, Xi'an
2025-10-01
Recruiting
Huashan Hospital
Phase 2/3
215
Beijing, Chengdu, Fuzhou, Guangzhou, Jinan, Nanchang, Nanjing, Shanghai
2025-10-01
Active, closed
Shanghai Zhongshan Hospital
Observational
10
Shanghai
2025-10-01
Not yet open
Changhai Hospital
Phase 2/3
180
Shanghai
2025-10
Not yet open
L & L Bio Co., Ltd., Ningbo, China
Phase 2/3
120
Shanghai
2025-10
Not yet open
Xi Junjie
Phase 2
25
Shanghai
2025-10
Not yet open
Innovent Biologics (Suzhou) Co. Ltd.
Observational
50
Shanghai
2025-10
Not yet open
Beijing Friendship Hospital
Not applicable
256
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-09-30
Recruiting
SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd Treatment
NCT07182721HER2-positive, Unresectable, Locally Advanced or Metastatic Breast Cancer, SKB264, Inetetamab
DrugsInetetamab·Sacituzumab tirumotecan
Fudan University
Phase 2
48
Shanghai
2025-09-30
Recruiting
Shanghai Novamab Biopharmaceuticals Co., Ltd.
Phase 2
216
Shanghai
2025-09-30
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2
210
Shanghai
2025-09-30
Active, closed
Shanghai Zhongshan Hospital
Phase 2
45
Nanjing, Shanghai
2025-09-30
Not yet open
Tongji University
Observational
150
Shanghai
2025-09-30
Not yet open
Second People's Hospital, Shanghai
Observational
50
Shanghai
2025-09-30
Active, closed
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Not yet open
Fudan University
Phase 2
30
Shanghai
2025-09-30
Recruiting
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
NCT07122401Secondary Hyperparathyroidism, Chronic Kidney Disease
DrugMT1013
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Phase 3
424
Shanghai
2025-09-30
Not yet open
A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy
NCT07175584Hemorrhoidal Disease, Cervical Cancer Radiation Complications
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
300
Shanghai
2025-09-29
Active, closed
Wenjin Yin
Observational
2,467
Shanghai
2025-09-28
Recruiting
Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
NCT07187635Bladder Cancer, Liquid Biopsy, Repeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital
Not applicable
350
Nanchang, Guangzhou, Xingtai, Kunming, Shanghai, Tianjin
2025-09-28
Recruiting
Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
NCT07083154Dementia, Mild, Mild Cognitive Impairment, Type 2 Diabetes
DrugMazdutide
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3
420
Changsha, Changzhou, Nanjing, Dalian, Shanghai
2025-09-27
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
37
Hefei, Shanghai
2025-09-25
Recruiting
Fudan University
Phase 2
60
Shanghai
2025-09-25
Recruiting
Wenjin Yin
Phase 2
123
Shanghai
2025-09-25
Active, closed
Ruijin Hospital
Observational
20
Shanghai
2025-09-24
Recruiting
T-DXd With or Without Neratinib for HER2 Positive Breast Cancer With Brain Metastasis
NCT07152782Breast Cancer With Brain Metastasis, HER2-positive Breast Cancer
DrugsNeratinib·Trastuzumab deruxtecan
Fudan University
Phase 2
202
Shanghai
2025-09-24
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
490
Harbin, Shanghai
2025-09-24
Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
NCT07058519Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
DrugOsimertinib
Shanghai Chest Hospital
Phase 2
250
Shanghai
2025-09-23
By invitation
Shanghai Huicun Medical Technology Co., Ltd.
Phase 1/2
39
Shanghai
2025-09-23
Recruiting
Lee's Pharmaceutical Limited
Phase 1
100
Zhengzhou, Shanghai
2025-09-23
Active, closed
Galderma R&D
Phase 3
561
Shanghai
2025-09-23
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
150
Shanghai, Tianjin
2025-09-23
Recruiting
Shanghai Chest Hospital
Phase 2
96
Hefei, Beijing, Zhengzhou, Shanghai
2025-09-22
Recruiting
Ruijin Hospital
Not applicable
25
Shanghai
2025-09-22
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
424
Harbin, Shanghai, Hangzhou
2025-09-22
Recruiting
Fudan University
Observational
45
Shanghai
2025-09-22
Recruiting
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
Phase 1/2
90
Shanghai
2025-09-22
Recruiting
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
NCT07162012NK/T-cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), DLBCL
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
24
Shanghai
2025-09-20
Recruiting
Akeso
Phase 2
160
Shanghai, Tianjin
2025-09-19
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
NCT07170800Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
DrugDelamanid
WestVac Biopharma Co., Ltd.
Phase 2
60
Wuhan, Changsha, Nanjing, Jinan, Chengdu, Beijing, Shanghai
2025-09-19
Recruiting
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2
116
Shanghai
2025-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Xuzhou, Shanghai, Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou
2025-09-17
Recruiting
LaNova Medicines Limited
Phase 1/2
320
Shanghai
2025-09-17
Recruiting
Candid Therapeutics
Phase 1
44
Fuzhou, Guangzhou, Guiyang, Zhengzhou, Changchun, Shanghai, Taiyuan, Chengdu
2025-09-16
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
153
Shanghai, Chengdu
2025-09-16
Recruiting
The University of Hong Kong
Not applicable
208
Shanghai
2025-09-15
Not yet open
Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy
NCT07169864Breast Cancer, Chemotherapy Induced Peripheral Neuropathy (CIPN), Neoadjuvant Therapy
Jinsong Lu
Not applicable
44
Shanghai
2025-09-15
Not yet open
Fudan University
Observational
460
Shanghai
2025-09-15
Not yet open
Multicenter Validation Study on Autism Screening Using a Machine-assisted System
NCT07006948Autism Spectrum Disorder, Early Developmental Impairment, Language Development Disorders
Children's Hospital of Fudan University
Observational
1,000
Hefei, Xiamen, Liuzhou, Harbin, Kunshan, Xi'an, Shanghai, Chengdu
2025-09-15
Not yet open
Fudan University
Phase 2
33
Shanghai
2025-09-15
Recruiting
Changhai Hospital
Phase 4
1,366
Shanghai, Zhejiang
2025-09-15
Not yet open
Fudan University
Observational
418
Shanghai
2025-09-15
Recruiting
Shanghai Yueyang Integrated Medicine Hospital
Phase 2/3
66
Shanghai
2025-09-15
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
414
Beijing, Chengdu, Guangzhou, Hangzhou, Luoyang, Macau, Nanchang, Shanghai
2025-09-13
Recruiting
A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications
NCT07142980Advanced Solid Tumors Harboring RAS Mutations or Amplifications
DrugHRS-7172
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
120
Shanghai
2025-09-12
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
120
Shanghai
2025-09-12
Recruiting
Ruijin Hospital
Phase 2
50
Shanghai
2025-09-11
Recruiting
Salivary Cortisol and Hypercortisolism in Type 2 Diabetes
NCT07156370Hypercortisolism, Type 2 Diabetes (T2DM)
Shanghai 6th People's Hospital
Observational
500
Shanghai
2025-09-11
Recruiting
Ruijin Hospital
Phase 2
25
Shanghai
2025-09-10
Not yet open
Fudan University
Phase 2
288
Shanghai
2025-09-10
Active, closed
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
900
Shanghai
2025-09-10
Recruiting
Pfizer
Phase 3
140
Beijing, Guangzhou, Changsha, Shanghai, Chengdu, Hangzhou
2025-09-10
Recruiting
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Phase 2
30
Shanghai
2025-09-08
Recruiting
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
NCT07295938Mycobacterium Abscessus Pulmonary Disease
Shanghai University of Traditional Chinese Medicine
Phase 2
352
Beijing, Guangdong, Hefei, Nanchang, Shanghai
2025-09-08
Recruiting
Xian-Jun Yu
Phase 1
198
Shanghai
2025-09-07
Active, closed
Shanghai TTM-Bio Technology Co., Ltd
Phase 1
64
Bengbu, Shanghai
2025-09-06
Recruiting
Study on Carotenoid-Based Instrumental Index
NCT07198503Skin Carotenoid Status
ChinaNorm
Observational
600
Shanghai
2025-09-06
Recruiting
Changhai Hospital
Observational
406
Shanghai
2025-09-05
Recruiting
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
NCT07198165Rectal Cancer, Rectal Adenocarcinoma, Rectal Cancer, Radiotherapy, Rectal Cancer Patients
Ruijin Hospital
Phase 2
104
Shanghai
2025-09-05
Recruiting
Clinical Study of Cizutamig in Systemic Lupus Erythematosus
NCT07215663Systemic Lupus Erythematosus (SLE)
DrugCizutamig
Candid Therapeutics
Phase 1
47
Beijing, Guangzhou, Luoyang, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai
2025-09-04
Recruiting
Fudan University
Phase 2
30
Shanghai
2025-09-04
Recruiting
Neukio Biotherapeutics (Shanghai) Co., Ltd.
Early Phase 1
8
Shanghai
2025-09-04
Recruiting
Children's Hospital of Fudan University
Not applicable
120
Shanghai
2025-09-01
Recruiting
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease
NCT07165470Colonoscopy: Bowel Preparation, IBD - Inflammatory Bowel Disease
Changhai Hospital
Not applicable
500
Shanghai
2025-09-01
Recruiting
Jia Xiu
Not applicable
120
Shanghai
2025-09-01
Not yet open
Sanjun Cai
Phase 2
300
Shanghai
2025-09-01
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
210
Shanghai
2025-09-01
Recruiting
Ruijin Hospital
Observational
30
Shanghai
2025-09-01
Not yet open
Shanghai Chest Hospital
Not applicable
465
Beijing, Zhengzhou, Nanjing, Ningbo, Shanghai
2025-09-01
Recruiting
The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
NCT07527884Spinal Metastases, Spinal Tumor, Radiotherapy, Separation Surgery
Wei Xu
Not applicable
130
Shanghai
2025-09-01
Not yet open
Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia
NCT07087847Acute Leukemia, Acute Leukemia Refractory, Acute Myeloid Leukemia (AML), ALL (Acute B-Lymphoblastic Leukemia)
DrugTCRαβ
Ruijin Hospital
Not applicable
18
Shanghai
2025-09-01
Not yet open
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
NCT07156656Type A Aortic Dissection, Organ Failure, Multiple
DrugSivelestat sodium
Shanghai Zhongshan Hospital
Phase 4
236
Hefei, Fuzhou, Guangzhou, Shenzhen, Xi'an, Shanghai
2025-09-01
Not yet open
De-escalation Therapy in Stage I ER-Positive Breast Cancer: A Non-Inferiority Trial
NCT07153757Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Fudan University
Phase 3
2,934
Shanghai
2025-09-01
Recruiting
Fudan University
Phase 1/2
54
Shanghai
2025-09-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Not applicable
276
Shanghai
2025-09-01
Recruiting
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
NCT07183280Solid Pseudopapillary Neoplasm of the Pancreas
Fudan University
Observational
2,000
Shanghai
2025-09-01
Recruiting
Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
NCT07168122Healthy Adult, Cushing Syndrome, Adrenal Insufficiency
Shanghai 6th People's Hospital
Observational
220
Shanghai
2025-09-01
Recruiting
Changhai Hospital
Not applicable
180
Shanghai
2025-09-01
Active, closed
Shanghai Mental Health Center
Not applicable
30
Shanghai
2025-09-01
Recruiting
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826Clostridium Difficile Infection Recurrence, Ulcerative Colitis (UC), Crohn Disease (CD), Irritable Bowel Syndrome (IBS)
Chen QiYi
Observational
4,000
Shanghai
2025-09-01
Not yet open
Shanghai Chest Hospital
Observational
50
Shanghai
2025-09-01
Not yet open
RSPO3/SDC-1 Pathway Dysfunction in Alveolar Repair After ARDS in Older Adults
NCT07129330Acute Respiratory Distress Syndrome (ARDS), Age-related Impaired Alveolar Epithelial Repair
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2025-09-01
Recruiting
Fudan University
Observational
250
Shanghai
2025-09-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
18
Shanghai
2025-09-01
Not yet open
Fudan University
Not applicable
210
Shanghai
2025-09-01
Not yet open
Fudan University
Phase 2
36
Shanghai
2025-09-01
Recruiting
High-Resolution CT for Heart
NCT07169201Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
500
Shanghai
2025-09-01
Not yet open
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
NCT07153744Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)
DrugAspirin
Shanghai Hutchison Pharmaceuticals Limited
Phase 4
9,588
Shanghai
2025-09-01
Recruiting
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
NCT07135856Lung Cancer, Neoadjuvant Therapy
Shanghai Chest Hospital
Observational
400
Shanghai
2025-09-01
Recruiting
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
NCT07303023Nasopharyngeal Carcinoma (NPC)
Fudan University
Phase 3
462
Shanghai, Hangzhou, Chengdu, Chongqing
2025-09-01
Not yet open
RenJi Hospital
Phase 2
45
Shanghai
2025-09-01
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
200
Shanghai
2025-09-01
Recruiting
Fudan University
Observational
150
Shanghai
2025-09-01
By invitation
Fudan University
Observational
128
Shanghai
2025-09-01
By invitation
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
144
Shanghai
2025-09-01
Not yet open
Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT07172126Metastatic Castration-resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
291
Chongqing, Zhuhai, Shanghai
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Shanghai
2025-09
Not yet open
Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Not applicable
96
Shanghai
2025-09
Recruiting
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
NCT07174843Idiopathic Inflammatory Myopathies(IIM), Immune Thrombocytopenia(ITP), Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd
Early Phase 1
20
Shanghai
2025-09
Not yet open
Fudan University
Phase 4
232
Shanghai
2025-09
Not yet open
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1/2
32
Shanghai, Xi'an
2025-08-31
Recruiting
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-08-31
Recruiting
Shanghai Pudong Hospital
Phase 2
32
Shanghai
2025-08-31
Recruiting
Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients
NCT07164950Urothelial Carcinoma, Advanced Solid Tumors, Chemotherapy-Induced Peripheral Neuropathy, Antibody-drug Conjugates
Sheng Zhang
Not applicable
58
Shanghai
2025-08-30
Active, closed
Ruijin Hospital
Not applicable
3
Shanghai
2025-08-30
Recruiting
Wenjin Yin
Phase 2
186
Shanghai
2025-08-28
Recruiting
Wenjin Yin
Observational
118
Shanghai
2025-08-28
Recruiting
Fudan University
Phase 2
138
Shanghai
2025-08-28
Recruiting
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
280
Shanghai
2025-08-28
Recruiting
Wenjin Yin
Observational
229
Shanghai
2025-08-28
Recruiting
BioNTech SE
Phase 1/2
375
Beijing, Hefei, Henan, Hunan, Shandong, Shanghai, Sichuan, Zhejiang
2025-08-27
Recruiting
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
NCT07156253Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA 1 /2 and / or HRD
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
110
Shanghai
2025-08-26
Recruiting
SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers
NCT07080619TNBC - Triple-Negative Breast Cancer, HR+ Breast Cancer
Tianjin ConjuStar Biologics Co., Ltd.
Phase 2
120
Shanghai
2025-08-26
Not yet open
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
NCT07142863Osteosarcoma, Neoadjuvant Therapy, Neoadjuvant Chemotherapy, PD-L1 Antibody
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
23
Shanghai
2025-08-25
Not yet open
Intracochlear Injection of Glucocorticoid
NCT07134075Sudden Sensorineural Hearing Loss (SSNHL)
Eye & ENT Hospital of Fudan University
Phase 2
150
Shanghai
2025-08-25
Recruiting
Ruijin Hospital
Phase 2
30
Shanghai
2025-08-25
Recruiting
Huashan Hospital
Not applicable
72
Beijing, Shanghai
2025-08-25
Recruiting
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
NCT07181473Lung Cancer (NSCLC), Prostate Cancer, Esophageal Cancer, Solid Tumor Malignancies
Phrontline Biopharma
Phase 1
200
Zhengzhou, Wuhan, Hangzhou, Shanghai
2025-08-25
Recruiting
A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
NCT07552909Attention Deficit Hyperactivity Disorder (ADHD)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
146
Shanghai
2025-08-24
Recruiting
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
NCT07484243Rheumatoid Arthritis (RA), Rheumatoid Arthritis-Associated Interstitial Lung Disease, Difficult-to-Treat Rheumatoid Arthritis
Dongyi He
Observational
10,000
Shanghai
2025-08-22
Recruiting
Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation
NCT07380269Hearing Loss, Hearing Loss, Sensorineural, Deafness, Cochlear Implantation
Eye & ENT Hospital of Fudan University
Observational
300
Shanghai
2025-08-22
Recruiting
Grit Biotechnology
Early Phase 1
10
Shanghai
2025-08-22
Recruiting
GrandPharma (China) Co., Ltd.
Phase 2
120
Beijing, Nanjin, Shanghai
2025-08-22
Recruiting
Avistone Pharmaceutical（Ningbo）Co., LTD.
Phase 1/2
108
Zhengzhou, Shanghai
2025-08-22
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
96
Shanghai
2025-08-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
153
Beijing, Guangzhou, Shanghai, Hangzhou
2025-08-21
Recruiting
HuidaGene Therapeutics Co., Ltd.
Early Phase 1
6
Shanghai
2025-08-20
Recruiting
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
NCT07111832PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
DrugsTrastuzumab Rezetecan·Adebrelimab·Toripalimab·Paclitaxel
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
400
Beijing, Shanghai
2025-08-20
Recruiting
Fudan University
Phase 2
56
Shanghai
2025-08-20
Recruiting
Hansoh BioMedical R&D Company
Phase 1
63
Shanghai
2025-08-19
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsPRL-02·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Yangzhou, Tianjin, Hangzhou, Huaian, Shanghai
2025-08-19
Recruiting
Biotheus Inc.
Phase 2
100
Beijing, Guangzhou, Harbin, Wuhan, Changchun, Jinan, Shanghai, Chengdu
2025-08-19
Active, closed
Amgen
Phase 3
350
Beijing, Quanzhou, Harbin, Jiamusi, Zhengzhou, Nanchang, Jinan, Shanghai
2025-08-18
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
600
Shenyang, Shanghai
2025-08-18
Recruiting
Wayshine Biopharm, Inc.
Phase 2
40
Fuzhou, Wuhan, Shanghai, Tianjin
2025-08-18
Recruiting
SEEG-Guided DBS for Schizophrenia
NCT07671261Schizophrenia Disorders, Schizo Affective Disorder
Ruijin Hospital
Not applicable
46
Shanghai
2025-08-17
Recruiting
Shanghai Mental Health Center
Not applicable
18
Shanghai
2025-08-17
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Shanghai
2025-08-15
Recruiting
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
159
Beijing, Fuzhou, Guangzhou, Changchun, Shanghai
2025-08-15
Recruiting
Fudan University
Observational
50
Shanghai
2025-08-15
Recruiting
Evopoint Biosciences Inc.
Phase 1/2
176
Shanghai
2025-08-15
Recruiting
Chinese Academy of Sciences
Observational
200
Zhengzhou, Beijing, Shanghai
2025-08-15
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Phase 2
20
Shanghai
2025-08-15
Recruiting
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
NCT07117045Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, High-grade Pancreatic Intraepithelial Neoplasia, PDAC - Pancreatic Ductal Adenocarcinoma
Changhai Hospital
Observational
400,000
Shanghai, Jiaxing, Ningbo
2025-08-15
Recruiting
Fudan University
Phase 2
45
Shanghai
2025-08-15
Active, closed
Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial
NCT07492225Neoadjuvant Therapy, Urothelial Carcinoma Ureter, Upper Urinary Tract Urothelial Carcinoma
Changhai Hospital
Phase 2
120
Shanghai
2025-08-15
Active, closed
Ruijin Hospital
Not applicable
10
Shanghai
2025-08-14
Recruiting
Akeso
Phase 3
760
Beijing, Fuzhou, Shijiazhuang, Harbin, Shanghai, Tianjin
2025-08-14
Recruiting
Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography
NCT07128108Chronic Liver Injury, Mindray Hepatus 9 Ultrasound Diagnostic System
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
225
Shanghai
2025-08-14
Recruiting
Fudan University
Phase 2
141
Shanghai
2025-08-14
Recruiting
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
NCT07116083Coronary Artery Disease, Coronary Artery Disease (Left Main), Obstructive Coronary Artery Disease, Stent Implantation
Shanghai Zhongshan Hospital
Observational
290
Shanghai
2025-08-13
Active, closed
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
224
Shanghai
2025-08-12
Recruiting
Fudan University
Phase 3
196
Shanghai
2025-08-12
Not yet open
Shanghai Mental Health Center
Not applicable
60
Shanghai
2025-08-11
Recruiting
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
NCT07126873Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
EndoCell Therapeutics, Inc.
Phase 1/2
21
Shanghai
2025-08-11
By invitation
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Shanghai
2025-08-11
Not yet open
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
561
Shanghai
2025-08-10
Recruiting
Shanghai Zhongshan Hospital
Early Phase 1
5
Shanghai
2025-08-10
Not yet open
High-resolution Magnetic Resonance Vessel Wall Imaging of Plaques
NCT07125339Intracranial Atherosclerotic Stenosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
605
Shanghai
2025-08-10
Recruiting
Zhongshan Ketogenic Diet Study 1
NCT07117903Platelet Function and Thrombus Formation
Fudan University
Not applicable
80
Shanghai
2025-08-10
Recruiting
Neural Mechanism of Cerebrocardiac Syndrome Following Traumatic Brain Injury
NCT06958406Traumatic Brain Injury, Cerebrocardiac Syndrome
Shanghai 6th People's Hospital
Observational
90
Shanghai
2025-08-10
Recruiting
China Colorectal Cancer Screening Trial 1 (C-Cost1)
NCT07090291Colorectal Cancer, Advanced Adenoma
Zhejiang University
Not applicable
60,300
Guandong, Guangdong, Hebei, Nanjing, Shanghai, Sichuan, Zhejiang
2025-08-08
Active, closed
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
NCT07162181Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, B-cell Lymphoma
DrugPirtobrutinib
Eli Lilly and Company
Phase 2
13
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan
2025-08-07
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Hangzhou, Shanghai
2025-08-07
Active, closed
AstraZeneca
Phase 3
212
Beijing, Changsha, Chengdu, Chongqing, Nanjing, Shanghai, Tianjin, Wuhan
2025-08-07
Recruiting
Guangke Lenses in Congenital Cataract
NCT07778797Congenital Cataract
Eye & ENT Hospital of Fudan University
Not applicable
50
Shanghai
2025-08-06
Recruiting
Shanghai Siponuoyin Biotechnology Co Ltd
Early Phase 1
9
Shanghai
2025-08-06
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
129
Shanghai
2025-08-06
Recruiting
Hongxia Wang
Phase 4
60
Shanghai
2025-08-06
Not yet open
Ruijin Hospital
Phase 2
22
Shanghai
2025-08-05
Recruiting
China National Center for Cardiovascular Diseases
Early Phase 1
3,160
Beijing, Guangzhou, Shenzhen, Zhengzhou, Wuhan, Shanghai, Taiyuan, Chengdu
2025-08-05
Not yet open
Shanghai Zhongshan Hospital
Observational
48
Shanghai
2025-08-05
Recruiting
Suzhou Alphamab Co., Ltd.
Phase 1
60
Shanghai
2025-08-05
Recruiting
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
NCT07391839Hepatoma, Unresectable Hepatocellular Carcinoma (HCC)
Suzhou Mednovo Yi Medical Technology Co., Ltd.
Phase 1
40
Hefei, Fuzhou, Guangzhou, Nanjing, Jinan, Hangzhou, Henan, Shanghai
2025-08-04
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
450
Shanghai
2025-08-04
Recruiting
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 3
286
Shanghai
2025-08-04
Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 1
26
Shanghai
2025-08-04
Recruiting
Nutshell Therapeutics (Shanghai) Co., LTD.
Phase 1/2
220
Beijing, Guangzhou, Nanchang, Shanghai, Xi'an
2025-08-04
Recruiting
AbbVie
Phase 2/3
854
Beijing, Fuzhou, Guangzhou, Wuhan, Nanchang, Shanghai, Chengdu
2025-08-03
Not yet open
Fudan University
Phase 1/2
20
Anyang, Shanghai
2025-08-01
Recruiting
Fudan University
Phase 2
20
Shanghai
2025-08-01
Recruiting
Shanghai Fourth People's Hospital Tongji University
Observational
50
Shanghai
2025-08-01
Recruiting
hAM for Inferior RRD
NCT07081945Rhegmatogenous Retinal Detachment
Eye & ENT Hospital of Fudan University
Not applicable
50
Shanghai
2025-08-01
By invitation
Investigation on Risk Factors for Suicide Among Chinese Patients With Mood Disorders
NCT07281729Bipolar Disorder；Major Depressive Disorder；Mood Disorders
Shanghai Mental Health Center
Observational
25,000
Shanghai
2025-08-01
Recruiting
Ruijin Hospital
Observational
50
Shanghai
2025-08-01
Not yet open
Ruijin Hospital
Phase 2
44
Shanghai
2025-08-01
Active, closed
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study
NCT07149441Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation
DrugInfliximab
Shanghai 10th People's Hospital
Not applicable
94
Shanghai
2025-08-01
Recruiting
SightGlass Vision, Inc.
Not applicable
175
Changsha, Chengdu, Guangzhou, Shanghai, Tianjin
2025-08-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
192
Shanghai
2025-08-01
Not yet open
29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236Primary Hepatocellular Carcinoma
Junjie Xu
Observational
350
Hefei, Chaoyang, Fuzhou, Guangzhou, Zhengzhou, Shanghai, Hangzhou, Wenzhou
2025-08-01
Not yet open
HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
NCT07045558Unresectable Hepatocellular Carcinoma
RenJi Hospital
Observational
28
Shanghai
2025-08-01
Not yet open
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
NCT07047352Carbapenem-resistant Enterobacterales, Neutropenia, Hematological Malignancies
Shanghai Jiao Tong University School of Medicine
Not applicable
91
Shanghai
2025-08-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
149
Nanjing, Shanghai
2025-08-01
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
114
Zhengzhou, Nanchang, Shanghai
2025-08-01
Not yet open
Shanghai Changzheng Hospital
Observational
400
Shanghai
2025-08-01
Recruiting
Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
NCT07085169Colo-rectal Cancer, Third-line and Beyond Therapy, TAS 102, Bevacizumab
DrugsTrifluridine/Tipiracil·Bevacizumab
Ruijin Hospital
Phase 2
50
Sanming, Shanghai
2025-08-01
Not yet open
Fudan University
Not applicable
524
Shanghai
2025-08-01
Not yet open
The Efficacy and Safety of Puerarin in Obesity Treatment
NCT06968208Metabolic Diseases, Obesity/Therapy
Ruijin Hospital
Phase 2
80
Shanghai
2025-08-01
Not yet open
China-Japan Friendship Hospital
Observational
100,000
Beijing, Shanghai, Changsha, Guiyang, Hangzhou, Henan, Qingdao, Shenyang
2025-08-01
By invitation
Children's Hospital of Fudan University
Not applicable
136
Shanghai
2025-08-01
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
30
Shanghai
2025-08-01
Recruiting
Fudan University
Phase 2
138
Fuzhou, Anyang, Jinan, Kunming, Shanghai
2025-08-01
Not yet open
Ruijin Hospital
Phase 2
45
Shanghai
2025-08-01
Not yet open
Ruijin Hospital
Phase 1/2
50
Shanghai
2025-08-01
Recruiting
Jin Yang
Observational
100
Shanghai
2025-08-01
Not yet open
Yun Qian
Not applicable
248
Jinjiang, Yancheng, Shanghai
2025-08-01
Not yet open
A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease
NCT07085195Parkinson Disease (PD), Gene Therapy, Safety and Efficacy, Clozapine
DrugClozapine
Ruijin Hospital
Early Phase 1
6
Shanghai
2025-08-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
40
Shanghai
2025-08
Not yet open
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
NCT07024277Neuroendocrine Prostate Cancer
DrugZG006
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 2
60
Shanghai
2025-08
Recruiting
Shanghai Cell Therapy Group Co.,Ltd
Phase 1/2
12
Shanghai
2025-07-31
Active, closed
Pfizer
Phase 3
208
Beijing, Chongqing, Guangzhou, Changsha, Shanghai, Chengdu, Kunming, Hangzhou
2025-07-31
Not yet open
Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors
NCT07088588Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
105
Shanghai
2025-07-31
Recruiting
GeneSail Biotech (Shanghai) Co., Ltd.
Phase 1
32
Hefei, Fuzhou, Shenzhen, Zhengzhou, Changsha, Shanghai
2025-07-31
Not yet open
Yang Fan, MD
Phase 2
164
Beijing, Changsha, Shanghai, Xi’an, Hangzhou
2025-07-31
Not yet open
Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD
NCT07088744Gastric Cancer (Diagnosis), Gastric High-grade Intraepithelial Neoplasia, Gastric Low-grade Intraepithelial Neoplasia, Gastritis
Changhai Hospital
Observational
169
Nanning, Shenyang, Chengdu, Shanghai
2025-07-30
Recruiting
Shanghai Zhongshan Hospital
Not applicable
232
Shanghai
2025-07-30
Recruiting
Dizal Pharmaceuticals
Phase 1/2
220
Beijing, Guangzhou, Harbin, Changsha, Nanjing, Shengyang, Jinan, Shanghai
2025-07-30
Recruiting
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 3
500
Shanghai
2025-07-30
Recruiting
Ruijin Hospital
Not applicable
270
Shanghai
2025-07-30
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
31
Shanghai
2025-07-30
Recruiting
Eastern Hepatobiliary Surgery Hospital
Phase 1/2
30
Shanghai
2025-07-30
Recruiting
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
NCT07088211Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
39
Shanghai
2025-07-29
Recruiting
Iparomlimab and Tuvonralimab in HNSCC
NCT07090317Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
DrugIparomlimab and Tuvonralimab
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
30
Shanghai
2025-07-29
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
260
Shanghai
2025-07-28
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
DrugsCisplatin·Carboplatin·Pembrolizumab
Eli Lilly and Company
Phase 1
240
Chengdu, Shanghai, Wuhan
2025-07-28
Recruiting
AbbVie
Phase 3
120
Guangzhou, Zhengzhou, Changsha, Changchun, Shanghai, Hangzhou
2025-07-28
Not yet open
EEG-TMS Intervening Against Postoperative Delirium
NCT07100197Postoperative Delirium
RenJi Hospital
Not applicable
98
Shanghai
2025-07-27
Active, closed
Fudan University
Not applicable
160
Shanghai
2025-07-27
Recruiting
Shanghai Clinical Cohort - Adrenal Disease
NCT07191951Adrenal Disease
Shanghai Jiao Tong University School of Medicine
Observational
600
Shanghai
2025-07-25
Recruiting
Bin Cao
Phase 4
188
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
NCT07203404SLE, LN, ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis
Nanjing Bioheng Biotech Co., Ltd.
Early Phase 1
96
Shanghai
2025-07-24
Recruiting
Bin Cao
Phase 4
300
Hefei, Beijing, Guangzhou, Nanchang, Shanghai
2025-07-24
Recruiting
Pfizer
Phase 3
150
Beijing, Shenzhen, Changsha, Nanchang, Shanghai, Hangzhou
2025-07-24
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
102
Shanghai
2025-07-22
Active, closed
MHB018A Treatment in Patients With Active Thyroid Eye Disease
NCT06989918Thyroid Associated Ophthalmopathies
DrugMHB018A
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 3
108
Shanghai
2025-07-22
Not yet open
Akeso
Phase 1
60
Shanghai
2025-07-22
Recruiting
Abbisko Therapeutics Co, Ltd
Phase 1
266
Shanghai
2025-07-22
Recruiting
Incidence of 107 Lymph Node Metastasis
NCT07165184Esophageal Cancer
Fudan University
Observational
1,100
Shanghai
2025-07-21
Recruiting
Incidence of 106TBL Lymph Node Metastasis
NCT07165210Esophageal Cancer
Fudan University
Observational
1,852
Shanghai
2025-07-21
Recruiting
Discovery and Validation of Periodontitis Biomarkers
NCT07293481Periodontitis, Biomarker in Early Diagnosis, Saliva
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
228
Shanghai
2025-07-21
Recruiting
Changhai Hospital
Not applicable
126
Shanghai
2025-07-21
Not yet open
Ruijin Hospital
Not applicable
51
Shanghai
2025-07-20
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
201
Shanghai
2025-07-17
Recruiting
Dizal Pharmaceuticals
Phase 1/2
180
Shanghai
2025-07-16
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
173
Chongqing, Shanghai
2025-07-16
Recruiting
Shanghai Chest Hospital
Not applicable
384
Shanghai
2025-07-16
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2025-07-16
Rows per page Showing 1001–1500 of 3879
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,879 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,418 of the 3,879 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 756 have not yet opened recruitment, 598 are active but closed to new participants, and 107 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.